Mathias Wenes

4.2k total citations · 3 hit papers
20 papers, 2.6k citations indexed

About

Mathias Wenes is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mathias Wenes has authored 20 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Mathias Wenes's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and Immune cells in cancer (6 papers). Mathias Wenes is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and Immune cells in cancer (6 papers). Mathias Wenes collaborates with scholars based in Belgium, Switzerland and Spain. Mathias Wenes's co-authors include Massimiliano Mazzone, Pedro Romero, Ping‐Chih Ho, Sofie Deschoemaeker, Stanley Ching‐Cheng Huang, Sarah‐Maria Fendt, Xiaoyun Li, Andrea Casazza, Luca Tamagnone and Damya Laoui and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Mathias Wenes

20 papers receiving 2.6k citations

Hit Papers

Navigating metabolic pathways to enhance antit... 2013 2026 2017 2021 2019 2013 2024 100 200 300 400 500

Peers

Mathias Wenes
Sergey V. Novitskiy United States
Nika Cyrus United States
Juan Carlos Acosta United Kingdom
Geoffrey J. Markowitz United States
Quan Liao China
Dayana B. Rivadeneira United States
Janelle Simon United States
Sergey V. Novitskiy United States
Mathias Wenes
Citations per year, relative to Mathias Wenes Mathias Wenes (= 1×) peers Sergey V. Novitskiy

Countries citing papers authored by Mathias Wenes

Since Specialization
Citations

This map shows the geographic impact of Mathias Wenes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Wenes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Wenes more than expected).

Fields of papers citing papers by Mathias Wenes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Wenes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Wenes. The network helps show where Mathias Wenes may publish in the future.

Co-authorship network of co-authors of Mathias Wenes

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Wenes. A scholar is included among the top collaborators of Mathias Wenes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Wenes. Mathias Wenes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yang, Jiangqing Chen, Massimo Andreatta, et al.. (2024). IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nature Biotechnology. 42(11). 1693–1704. 144 indexed citations breakdown →
2.
Wenes, Mathias, Kinsey Maundrell, O. Barábas, et al.. (2024). A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacy. SHILAP Revista de lepidopterología. 32(4). 200897–200897. 2 indexed citations
3.
Johnson, Zoë, Chiara Tarantelli, Luciano Cascione, et al.. (2023). IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance. Cancer Research Communications. 3(4). 576–591. 10 indexed citations
4.
Jaccard, Alison, Tania Wyss, Noelia Maldonado‐Pérez, et al.. (2023). Reductive carboxylation epigenetically instructs T cell differentiation. Nature. 621(7980). 849–856. 71 indexed citations
5.
Ghasemi, Ali, Amaia Martínez-Usatorre, Mehdi Hicham, et al.. (2023). Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy. Nature Cancer. 5(2). 240–261. 43 indexed citations
6.
Maldonado‐Pérez, Noelia, María Tristán‐Manzano, Pilar Muñoz, et al.. (2022). Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma. Frontiers in Immunology. 13. 1011858–1011858. 15 indexed citations
7.
Wenes, Mathias, Alison Jaccard, Tania Wyss, et al.. (2022). The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function. Cell Metabolism. 34(5). 731–746.e9. 130 indexed citations
8.
Tschumi, Benjamin, Mathias Wenes, Haiping Wang, et al.. (2020). Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity. Cellular and Molecular Immunology. 18(7). 1761–1771. 118 indexed citations
9.
Li, Xiaoyun, Mathias Wenes, Pedro Romero, et al.. (2019). Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nature Reviews Clinical Oncology. 16(7). 425–441. 509 indexed citations breakdown →
10.
Conza, Giusy Di, Ana I. Oliveira, Manuel Ehling, et al.. (2017). Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis. Cell Reports. 21(10). 2842–2854. 48 indexed citations
11.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Scientific Reports. 6(1). 33453–33453. 183 indexed citations
12.
Wenes, Mathias, Min Shang, Mario Di Matteo, et al.. (2016). Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis. Cell Metabolism. 24(5). 701–715. 388 indexed citations
13.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). In Toxic Cirrhotic Rats, the FXR Agonist Obeticholic Acid Reduces Liver Fibrosis Indirectly via an Anti-Inflammatory Effect in Liver Sinusoidal Endothelial Cells and Kupffer Cells. Journal of Hepatology. 64(2). S141–S141. 1 indexed citations
14.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2015). P0445 : Obeticholic acid, an FXR agonist, reduces hepatic fibrosis in a rat model of toxic cirrhosis. Journal of Hepatology. 62. S479–S479. 1 indexed citations
15.
Hamm, Alexander, Hans Prenen, Mario Di Matteo, et al.. (2015). Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer. Gut. 65(6). 990–1000. 65 indexed citations
16.
Casazza, Andrea, Damya Laoui, Mathias Wenes, et al.. (2013). Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity. Cancer Cell. 24(6). 695–709. 477 indexed citations breakdown →
17.
Casazza, Andrea, Giusy Di Conza, Mathias Wenes, et al.. (2013). Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene. 33(14). 1743–1754. 203 indexed citations
18.
Hamm, Alexander, Lorenzo Veschini, Yukiji Takeda, et al.. (2013). PHD2 regulates arteriogenic macrophages through TIE2 signalling. EMBO Molecular Medicine. 5(6). 843–857. 34 indexed citations
19.
Tugues, Sònia, Satoshi Honjo, Christian König, et al.. (2012). Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization. Cancer Research. 72(8). 1953–1963. 36 indexed citations
20.
Korf, Hannelie, Mathias Wenes, Benoı̂t Stijlemans, et al.. (2012). 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology. 217(12). 1292–1300. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026